To put that in perspective, the approved GLP-1 drugs achieved less weight loss in longer timeframes: for example, semaglutide (Wegovy) averages about 15% weight loss over ~16 months, and tirzepatide (Zepbound) achieved around 22.5% at 72 weeks in trials
Why Oncologists Will Pay Attention Even with its limitations, this study lands at a moment when breast oncology is becoming increasingly interested in the role of body composition, insulin resistance, and metabolic intervention
Rewards Program Earn points on birthdays, product orders, reviews, friend referrals, and more
Detailed written instructions and drug information were in the box, along with a helpful visual showing patients how to draw up the syringe and inject
But if her insurance approves the brand name, her monthly cost could drop to as little as $25
Storage requirements vary significantly depending on which version you are using